Transcrip offers experts to augment in-house drug development
The international partnership consists of almost 20 pharma industry experts and academics who work with clients’ in-house drug development teams on a contractual basis.
As Branthwaite explained Transcrip aims to “provide knowledge and operational capability in drug development in its widest context, working across multiple therapeutic and ‘functional’ areas.”
“Already substantial by consulting group standards in the pharma space, it offers a flexible resourcing model that allows clients to access Partners’ capabilities to fill skill, experience and/or resource gaps, by integrating with and augmenting client teams.”
